Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccinations01:51

Vaccinations

52.5K
Overview
52.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Test of CP Symmetry in the Neutral Decays of Λ via J/ψ→ΛΛ[over ¯].

Physical review letters·2026
Same author

Precise Measurement of the Chromoelectric Dipole Moment of the Charm Quark.

Physical review letters·2026
Same author

Precise Measurement of Matter-Antimatter Asymmetry with Entangled Hyperon-Antihyperon Pairs.

Physical review letters·2026
Same author

Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}.

Physical review letters·2026
Same author

First Measurement of the D_{s}^{+}→K^{0}μ^{+}ν_{μ} Decay.

Physical review letters·2026
Same author

Observation of the Electromagnetic Radiative Decays of the Λ(1520) and Λ(1690) to γΣ^{0}.

Physical review letters·2026

Related Experiment Video

Updated: Mar 1, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.8K

The next chapter for group B meningococcal vaccines.

N Y Wang1,2, A J Pollard2,3

  • 1a School of Medicine , Monash University , Melbourne , Australia.

Critical Reviews in Microbiology
|May 31, 2017
PubMed
Summary

New group B meningococcal vaccines show promise for controlling endemic disease in infants. Evidence of reduced carriage acquisition is crucial for herd immunity, despite challenges with dosing and reactogenicity.

Keywords:
Neisseria meningitidisfactor H binding proteinmeningococcal diseaseouter membrane vesiclerecombinant protein

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.8K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.9K
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.7K

Area of Science:

  • Vaccinology
  • Microbiology
  • Epidemiology

Background:

  • Group B Neisseria meningitidis is the primary cause of invasive meningococcal disease (IMD) in developed nations.
  • Past vaccine successes against this pathogen were limited to specific clonal outbreaks.
  • The UK's routine infant immunization program marks a new era in controlling endemic group B IMD.

Purpose of the Study:

  • To review key developments in group B meningococcal vaccine research.
  • To discuss factors influencing the control of endemic group B IMD.
  • To assess the potential impact of new vaccines on disease control and future strategies.

Main Methods:

  • Review of historical and current group B meningococcal vaccine development.
  • Analysis of early data from the UK's routine infant immunization program.
  • Discussion of immunological and epidemiological evidence related to vaccine efficacy and herd immunity.

Main Results:

  • New group B meningococcal vaccines are being implemented for routine infant immunization in the UK.
  • Evidence of reduced carriage acquisition in adolescents post-vaccination is essential for herd immunity.
  • Challenges include the need for multiple doses and vaccine reactogenicity.

Conclusions:

  • Early UK data suggest new group B meningococcal vaccines can significantly impact disease rates.
  • Achieving population control requires demonstrating reduced carriage acquisition to enable herd immunity.
  • Further insights into vaccine effectiveness and future improvements are anticipated.